LABFF OTC
Laboratorios Farmaceuticos Rovi, S.A.
1W: +0.0%
1M: +0.0%
3M: -25.0%
YTD: -25.9%
1Y: -25.9%
3Y: +34.9%
5Y: +4.7%
$67.17
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$955M
+14.8% ▲
5Y CAGR: +10.7%
Total Liabilities
$277M
+10.5% ▲
5Y CAGR: +6.6%
Shareholders Equity
$664M
+16.1% ▲
5Y CAGR: +12.2%
Cash & Investments
$98M
+257.3% ▲
5Y CAGR: +13.0%
Total Debt
$146M
+27.6% ▲
5Y CAGR: +14.7%
Net Debt
$48M
-44.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $99M | $125M | $25M | $27M | $98M |
| Short-Term Investments | $0 | $0 | $113K | $227K | $0 |
| Cash & ST Investments | $99M | $125M | $25M | $27M | $98M |
| Net Receivables | $130M | $160M | $125M | $144M | $178M |
| Inventory | $245M | $312M | $338M | $330M | $288M |
| Other Current Assets | $30M | $24M | $19M | -$12M | $3M |
| Total Current Assets | $506M | $623M | $509M | $490M | $569M |
| Property, Plant & Equip. | $182M | $216M | $254M | $287M | $331M |
| Goodwill & Intangibles | $39M | $36M | $28M | $34M | $36M |
| Long-Term Investments | $2M | $2M | $591K | $19M | $19M |
| Other Non-Current Assets | $0 | $0 | $9M | $292K | $3 |
| Total Non-Current Assets | $226M | $256M | $291M | $342M | $386M |
| Total Assets | $733M | $879M | $800M | $832M | $955M |
| — Liabilities — | |||||
| Accounts Payable | $99M | $126M | $108M | $87M | $68M |
| Short-Term Debt | $3M | $8M | $8M | $18M | $44M |
| Deferred Revenue | $58M | $115M | $0 | $0 | $4M |
| Other Current Liabilities | $60M | $124M | $46M | $5M | $53M |
| Total Current Liabilities | $190M | $294M | $200M | $157M | $181M |
| Long-Term Debt | $53M | $46M | $39M | $81M | $93M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | -$9M |
| Total Non-Current Liabilities | $71M | $63M | $57M | $94M | $96M |
| Total Liabilities | $262M | $357M | $256M | $250M | $277M |
| — Equity — | |||||
| Common Stock | $3M | $3M | $3M | $3M | $3M |
| Retained Earnings | $445M | $456M | $556M | $486M | $578M |
| Accumulated OCI | $671K | $665K | -$21K | $0 | $619K |
| Total Stockholders Equity | $471M | $520M | $539M | $572M | $664M |
| Total Liabilities & Equity | $733M | $879M | $800M | $832M | $955M |
| — Key Metrics — | |||||
| Total Debt | $73M | $72M | $65M | $114M | $146M |
| Net Debt | -$26M | -$53M | $40M | $87M | $48M |
| Total Investments | $2M | $2M | $704K | $20M | $19M |